Tamsulosin + Tadalafil Blended Pellets
Tamsulosin HCL + Tadalafil Blended Pellets – Combination Alpha Blocker and PDE5 Inhibitor Pellets for BPH Programs. Rraynex Tamsulosin HCL + Tadalafil Blended Pellets are developed as a dual-API blended pellet system combining alpha blocker and phosphodiesterase inhibitor characteristics for combination BPH formulations.
Product overview
This blended combination is structured as a multiparticulate platform where both APIs are presented in a coordinated pellet matrix to support capsule filling and reproducible handling. Rraynex focuses on blend uniformity, particle-size control and formulation-specific dissolution. Technical specifications are available upon request.
Key characteristics
- Blended dual-API pellet platform.
- Controlled blend uniformity for capsule filling.
- Suitable for BPH combination therapy development.
- Technical support for formulation optimization and commercial supply.
Product specifications
- Product
- Tamsulosin + Tadalafil Blended Pellets
- Form
- blended Pellets
- Therapeutic category
- Alpha-Blocker + PDE5 Inhibitor
- Strength
- 0.2% + 5%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Tamsulosin + Tadalafil Blended Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Tamsulosin products from Rraynex
- Tamsulosin + Dutasteride — Pellets
- Tamsulosin + Dutasteride (0.4% + 0.5%) — Pellets
- Tamsulosin HCl SR — Pellets
- Tamsulosin HCl SR (WW) — Pellets
- Tamsulosin HCl SR + Dutasteride IR (WW) — Pellets